What is Traws Pharma Inc (TRAW) stock price today?

Traws Pharma Inc (TRAW) currently trades at $1.43 per share. The stock has a market capitalization of $11.58M and a P/E ratio of 1.39x.

Is TRAW stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Traws Pharma Inc has a Smart Value Score of 31/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Traws Pharma Inc's revenue and earnings?

Traws Pharma Inc has trailing twelve-month (TTM) revenue of $2.79M with profit margins of 328.70%. Earnings per share (EPS) is $0.82.

TRAW

Traws Pharma Inc

NASDAQ: TRAW · HEALTHCARE · BIOTECHNOLOGY

$1.43

+10.00% today

Updated 2026-04-30

Market cap

$11.58M

P/E ratio

1.39

P/S ratio

4.15x

EPS (TTM)

$0.82

Dividend yield

—

52W range

$1 – $3

Volume

0.2M

Market cap

$11.58M

P/E ratio

1.39

P/S ratio

4.15x

EPS (TTM)

$0.82

Dividend yield

—

52W range

$1 – $3

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

5.3

Growth

C+

5.0

Quality

C+

4.0

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$5.50

+284.62%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Profit margin 328.70% — above average

Risks

- Negative free cash flow $-6.60M

- Revenue declining -100.00% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$226000.00	$226000.00	$226000.00	$2.79M	$2.79M
Net income	$-18.96M	$-18.95M	$-54.67M	$9.17M	$-3.04M
EPS	—	—	—	—	$0.82
Free cash flow	$-16.29M	$-17.95M	$-29.79M	$-20.77M	$-6.60M
Profit margin	-8,391.15%	-8,384.07%	-24,192.04%	328.67%	328.70%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
TRAW	$11.58M	31	5.3	4.0	6.7	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Traws Pharma Inc trades at $1.43. representing a P/E of 1.39x trailing earnings. Our Smart Value Score of 31/100 indicates the stock is weak. TTM revenue stands at $2.79M. with profit margins at 328.70%.

Frequently asked questions

What is Traws Pharma Inc's stock price?

Traws Pharma Inc (TRAW) trades at $1.43.

Is Traws Pharma Inc overvalued?

Smart Value Score 31/100 (Grade F, Strong Sell).

What is the price target of Traws Pharma Inc (TRAW)?

The analyst target price is $5.50, representing +284.6% upside from the current price of $1.43.

What is Traws Pharma Inc's revenue?

TTM revenue is $2.79M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio4.15x

ROE-1,060.00%

Beta1.62

50D MA$1.68

200D MA$1.88

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

TRAW vs LLY →TRAW vs JNJ →TRAW vs ABBV →Stock screener →